Life Settlement Fund

Institutional life settlement investing, built with underwriting discipline.

Aurevia Capital is building a modern investment platform for life settlements designed around rigorous case selection, explainable pricing logic, conservative reserve framing, and clean execution standards.

Focus U.S. life settlements

Case-by-case underwriting and disciplined capital deployment across the policy lifecycle.

Process Underwrite, price, govern

Decision quality supported by structured review, documented assumptions, and controlled workflows.

Edge ML/AI-enabled tools

Proprietary models support medical synthesis, policy mechanics analysis, and more disciplined pricing.

Fund overview

Aurevia Capital is being built as a disciplined life settlement investment platform for investors who value underwriting depth, transparent logic, and institutional-grade operating standards.

Investment focus

The firm is focused on U.S. life settlement opportunities where better underwriting, cleaner policy analysis, and conservative reserve framing can materially improve decision quality.

  • Policy-level review rather than surface screening
  • Institutional underwriting discipline and documentation
  • Capital deployment framed around selectivity and control

Pricing philosophy

Aurevia is built around explainable decision-making. The goal is to make each price or pass decision understandable, defensible, and consistent under institutional review.

  • Transparent assumptions behind pricing conclusions
  • Sensitivity awareness around premiums and duration
  • Cleaner alignment between analysis and execution

Capital stewardship

The platform is designed to pair data-driven underwriting with measured judgment, governance discipline, and a long-term approach to portfolio construction.

  • Reserve-aware case evaluation
  • Repeatable workflows and process controls
  • Allocator-ready external presentation
Valentin Lepinay, Founder and Managing Partner of Aurevia Capital
Leadership

Founder-led judgment, disciplined by data and process.

Valentin Lepinay, Founder and Managing Partner

Valentin Lepinay founded Aurevia Capital to bring a more rigorous, analytically grounded standard to life settlement investing. His background spans quantitative investing, applied mathematics, machine learning, and complex risk analysis.

At Aurevia, he is building a platform designed around disciplined underwriting, explainable pricing logic, conservative reserve thinking, and repeatable execution standards that can hold up under institutional scrutiny.

“Better outcomes in life settlements come not from optimism, but from tighter analysis, cleaner policy evaluation, and consistent risk control.”

Our approach

Aurevia combines underwriting discipline, policy analytics, and governance-minded execution to build a life settlement platform that feels both modern and institutionally credible.

Underwriting and analytics

The platform is designed to move beyond surface screening and toward a more structured investment process that incorporates medical synthesis, policy mechanics, premium evaluation, and scenario awareness.

  • Structured medical review and life expectancy framing
  • Premium burden and policy mechanics analysis
  • Clear reasoning behind action and pass decisions

Governance and execution

Aurevia is being built with documentation standards, decision discipline, and cleaner process control so execution can remain aligned with underwriting intent.

  • Documented underwriting logic
  • Institutional process control and repeatability
  • Allocator-ready narrative and workflow clarity

Contact Aurevia Capital

We welcome direct inquiries regarding the following:

  • Investor and allocator introductions
  • Broker and provider relationships
  • Strategic and institutional partnership discussions
  • General firm inquiries

For direct outreach, you can also email contact@aureviacapital.com.

Contact the firm

Briefly describe your inquiry, relationship type, or area of interest.